A recurrent ovarian cancer patient with a history of nine prior chemotherapy regimens who was safely treated with weekly paclitaxel plus bevacizumab and achieved a complete response: a case report

Herein, we describe our experience with a recurrent ovarian cancer patient who was treated safely with bevacizumab and who achieved a complete response despite receiving nine prior chemotherapy regimens. The patient was a 54-year-old woman with stage IIIC recurrent ovarian serous adenocarcinoma (gra...

Descripción completa

Detalles Bibliográficos
Autores principales: Takatori, Eriko, Shoji, Tadahiro, Nagasawa, Takayuki, Takeuchi, Satoshi, Hosoyachi, Akira, Sugiyama, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540113/
https://www.ncbi.nlm.nih.gov/pubmed/26316778
http://dx.doi.org/10.2147/OTT.S80143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540113/
https://www.ncbi.nlm.nih.gov/pubmed/26316778
http://dx.doi.org/10.2147/OTT.S80143

Ejemplares similares